Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland

被引：0
|
作者：
C. A. Jackson
N. R. V. Jones
J. J. Walker
C. M. Fischbacher
H. M. Colhoun
G. P. Leese
R. S. Lindsay
J. A. McKnight
A. D. Morris
J. R. Petrie
N. Sattar
S. H. Wild
机构：
[1] Western General Hospital,Scottish Collaboration for Public Health Research and Policy, MRC Human Genetics Unit
[2] University of Edinburgh,Centre for Population Health Sciences
[3] Medical School,Information Services Division
[4] NHS National Services Scotland,Medical Research Institute
[5] University of Dundee,British Heart Foundation Glasgow Cardiovascular Research Centre
[6] Ninewells Hospital & Medical School,Metabolic Unit
[7] University of Glasgow,undefined
[8] Western General Hospital,undefined
来源：
Diabetologia | 2012年 / 55卷
关键词：
Cerebrovascular disorders; Diabetes mellitus; Epidemiology; Myocardial ischaemia; Scotland; Socioeconomic factors; Type 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2938 / 2945
页数：7
相关论文
共 50 条
  • [31] A decade of socioeconomic inequality in type 2 diabetes area-level prevalence: an unshakeable status quo?
    Tapager, Ina
    Bender, Anne Mette
    Andersen, Ingelise
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2023, 51 (02) : 268 - 274
  • [32] Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California
    Bakhsh, Yasser
    Readhead, Adam
    Flood, Jennifer
    Barry, Pennan
    JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2023, 25 (03) : 643 - 652
  • [33] Workplace robberies in context: The role of area-based socioeconomic factors
    Ta, M.
    Marshall, S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S118 - S118
  • [34] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Leitner, H.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2016, 9 (01): : 22 - 22
  • [35] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2016, 23 (1-2): : 54 - 54
  • [36] Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes
    Chonchol, Michel
    Dale, Rita
    Schrier, Robert W.
    Estacio, Raymond
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04): : 380 - 386
  • [37] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Rosenstein, Robert
    Hough, Augustus
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11): : 1093 - 1094
  • [38] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Zinman, Bernard
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22): : 2117 - 2128
  • [39] Relationship between the shift of socioeconomic status and cardiovascular mortality
    Sung, Jidong
    Song, Yun-Mi
    Hong, Kyung Pyo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (07) : 749 - 757
  • [40] Socio-economic status, incidence of type 2 diabetes and relative mortality in Scotland 2001-2007
    Wild, S. H.
    DIABETOLOGIA, 2010, 53
12345